Patents by Inventor Mingshu Wang

Mingshu Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220177477
    Abstract: The present invention relates to the field of biomedicine, and discloses a pyrazolopyrimidine compound, a pharmaceutical composition, and an application therefor, the oxygen-containing substituted pyrazolopyrimidine compound having the structure shown in formula (I). The oxygen-containing substituted pyrazolopyrimidine compound having the structure shown in formula (I) provided in the present invention or a pharmaceutically acceptable salt, a stereoisomer, a geometric isomer, a tautomer, a nitrogen oxide, a hydrate, a solvate, a metabolite, or a prodrug thereof demonstrate excellent inhibitory activity against TRK kinase, and demonstrate good anti-tumour activity at the animal level.
    Type: Application
    Filed: March 19, 2020
    Publication date: June 9, 2022
    Applicant: Central China Normal University
    Inventors: Guangfu Yang, Wei Huang, Linsheng Zhuo, Hongchuang Xu, Mingshu Wang
  • Patent number: 11033617
    Abstract: Disclosed herein are a duck hepatitis A virus type 3 (DHAV-3) mutant CH-P60-117C and a construction method thereof. The DHAV-3 mutant CH-P60-117C is constructed by mutating A at position 117 of 5?-UTR of the genome of the DHAV-3 virulent strain to C; mutating T at position 1142 to A to mutate tyrosine-164 of VP0 protein of the parent strain to asparagine; and mutating C at position 4334 to A so that leucine-71 of the viral protein 2C of the parent strain is mutated to isoleucine.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: June 15, 2021
    Assignee: SICHUAN AGRICULTURAL UNIVERSITY
    Inventors: Anchun Cheng, Xingjian Wen, Mingshu Wang, Liping Wu
  • Publication number: 20210008196
    Abstract: Disclosed herein are a duck hepatitis A virus type 3 (DHAV-3) mutant CH-P60-117C and a construction method thereof. The DHAV-3 mutant CH-P60-117C is constructed by mutating A at position 117 of 5?-UTR of the genome of the DHAV-3 virulent strain to C; mutating T at position 1142 to A to mutate tyrosine-164 of VP0 protein of the parent strain to asparagine; and mutating C at position 4334 to A so that leucine-71 of the viral protein 2C of the parent strain is mutated to isoleucine.
    Type: Application
    Filed: July 6, 2020
    Publication date: January 14, 2021
    Inventors: Anchun CHENG, Xingjian WEN, Mingshu WANG, Liping WU
  • Publication number: 20080013641
    Abstract: One embodiment of the present invention provides a data transmission method, including: performing a serial-to-parallel conversion for input date stream, obtaining 4 parallel data streams and partitioning the 4 parallel data streams into 2 groups; performing trellis encoding for one group and selecting one basic codeword subset from all basic codeword subsets according to the trellis encoding output; performing trellis encoding for one data stream in the other group and selecting one phase subset from all phase subsets according to the trellis encoding output, and selecting a phase value from the selected phase subset according to another data stream in the other group; rotating the codeword selected from the basic codeword subset by the selected phase value and obtaining and transmitting an output codeword to a data receive-side. One embodiment of the present invention also includes another data transmission method and two data transmission apparatuses.
    Type: Application
    Filed: June 21, 2007
    Publication date: January 17, 2008
    Inventors: Anxin Li, Mingshu Wang, Xiangming Li, Hidetoshi Kayama